BioNTech CEO and co-founder Ugur Sahin said in an exclusive interview with CNN that the vaccine they are developing with Pfizer is "almost perfect."
The executive added that they are confident that they can have a vaccine against the new coronavirus ready for regulatory approval in mid-October.